Trial Profile
A Randomized Controlled Trial of Wound Infiltration With Extended-release Versus Short-acting Bupivacaine Before Laparoscopic or Robotic Hysterectomy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2020
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- 12 Apr 2016 Status changed from recruiting to completed according to the ClinicalTrials.gov record.
- 14 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Feb 2015 New trial record